Purchase Order 75N93021P01024

Life Technologies Corporation, operating as Thermo Fisher Scientific, received a $80,000 firm fixed price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) on July 26, 2021, with an ultimate completion date of July 26, 2022. The contract award was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of the period of availability for these fiscal year funds. The work is performed in Carlsbad, California, where Life Technologies maintains its headquarters. No set-aside designation was applied to this procurement, reflecting the contractor's competitive positioning in open federal acquisition.

As a leading manufacturer of scientific instruments, reagents, and consumables, Life Technologies maintains an extensive portfolio of federal contracts across the National Institutes of Health, Department of Defense, Centers for Disease Control and Prevention, and other agencies. The company supplies sophisticated laboratory instrumentation and critical research consumables that support NIAID's mission in infectious disease research and diagnostics. Life Technologies has demonstrated consistent success in federal procurement since its SAM.gov registration in April 2002, establishing itself as a cornerstone supplier of advanced biotechnology infrastructure to support federal research and public health initiatives.